TAK

MKT CAP:$48B

Takeda Pharmaceutical Co Ltd ADR

Market Cap

$48B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NYSE

Healthcare·Drug·🇺🇸·NYSE

Stock Price

$15.74+$0.38 (+2.44%)

Jun 8, 2026

52W High $18.7752W Low $13.01

Company Details

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterolog...

CEO

—

IPO Date

Oct 27, 2008

Website

www.takeda.com

Key Metrics TTM (JPY)

Revenue

¥4.5T

-0.7% YoY

Net Income

¥193.2B

EPS (Diluted)

Free Cash Flow

¥757.2B

Revenue / Share

¥1,455.16

Gross Margin

58.5%

Operating Margin

10.9%

Net Margin

4.2%

FCF Margin

16.7%

P/S

P/E

Earnings Reports

Q1 2027

Jul 30, 2026

PENDING

FY 2026

May 26, 2026

¥4.8T+4.3%

Q4 2026

May 26, 2026

¥1.1T+5.8%

Q3 2026

Jan 29, 2026

¥1.2T+6.0%

Q2 2026

Oct 30, 2025

¥1.1T-5.4%

Revenue & Profitability (JPY)

Operating Cash Flow (JPY)

CapEx Spend (JPY)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (JPY)

OpEx Breakdown (JPY)

War Chest (JPY)

Shares Outstanding

Revenue Per Employee (JPY)

Revenue / Employee